About Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Side effect(s) of Canagliflozin

Read the side effects of Canagliflozin as described in the medical literature. In case of any doubt consult your doctor or pharmacist.

Most Common - Female genital mycotic infections, urinary tract infection and increased urination.

Gastrointestinal - Increased thirst, constipation, nausea and vomiting.

Other Precautions : * Avoid excess dosage.

Drug Name : Canagliflozin

Canagliflozin(Invokana) generic is an antidiabetic (sodium glucose co-transporter 2 (SGLT2) inhibitor), prescribed for type 2 diabetes mellitus along with diet and exercise. For patients with type 2 diabetes along with diabetic kidney disease, physicians should consider using an SGLT2 inhibitor when the eGFR is at or above 30, especially with albuminuria above 300 mg/g, to lower renal and CV risk as per A.D.A recommendations.
More Info about Canagliflozin

Advertisement



Advertisement
Recommended Reading
Drugs A - Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Drugs Search


    Advertisement
    What's New on Medindia
    Are Menopause Symptoms Troubling You?: Try these Options
    Vaccination  And Counter  Measures Against  Monkeypox
    Indian Railways Special Concession on Health Grounds
    View all

    Medindia Newsletters Subscribe to our Free Newsletters!
    Terms & Conditions and Privacy Policy.

    Most Popular on Medindia

    Blood Donation - Recipients Sinopril (2mg) (Lacidipine) The Essence of Yoga Drug Interaction Checker Calculate Ideal Weight for Infants Hearing Loss Calculator Selfie Addiction Calculator Sanatogen Iron Intake Calculator Diaphragmatic Hernia

    Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

    © All Rights Reserved 1997 - 2022

    This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use